High-flow Nasal Cannula Market Size

High Flow Nasal Cannula Market size was valued at USD 11.26 billion in 2024 and is expected to cross USD 48.57 billion by the end of 2037, registering more than 11.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of high-flow nasal cannula is estimated at USD 12.33 billion. The growth of the market is primarily attributed to the radically increasing cases of asthma along with chronic obstructive pulmonary diseases across the globe. As per the World Health Organization, globally, asthma is expected to have killed 455 000 people in 2019 and impacted 262 million people in the same year. Increasing air pollution is caused by the presence of particulate matter and ozone, and an increasing number of indoor air pollutants, which include tobacco smoke, dust mites, cockroaches, mold & pesticides. The pollution caused by fossil fuel combustion, the growing number of industries, transportation, and the rising use of chemicals across the world is estimated to propel the growth of the market.

The nasal cannula is used in cases where people are not able to breathe or get sufficient oxygen for the proper functioning of the body. This is a common phenomenon among patients who are suffering from asthma, COPD, or any other respiratory illness. In addition to this, the high-flow nasal cannula market is estimated to grow on the basis of the rising prevalence of asthma and respiratory tract illnesses among children across the world. Also, asthma is the most common chronic condition affecting children as per the reports. As per the estimations, about 5.1 million asthmatic children are under the age of 18. Moreover, about, 11 Americans die from asthma every day, and asthma-related deaths reached to 4,145 in the year 2020. Besides this, the launch of novel advanced products by the key manufacturers is another major factor that is fueling the growth of the market over the projected period.